253 related articles for article (PubMed ID: 15918144)
1. Prevention of hepatocellular carcinoma.
Colombo M; Donato MF
Semin Liver Dis; 2005; 25(2):155-61. PubMed ID: 15918144
[TBL] [Abstract][Full Text] [Related]
2. Prevention of hepatocellular carcinoma in hepatitis B virus infection.
Lim SG; Mohammed R; Yuen MF; Kao JH
J Gastroenterol Hepatol; 2009 Aug; 24(8):1352-7. PubMed ID: 19702903
[TBL] [Abstract][Full Text] [Related]
3. [Strategies for the prevention of hepatocellular carcinoma in the context of chronic viral hepatitis].
Schott E; Bergk A; Berg T
Z Gastroenterol; 2008 Jan; 46(1):69-80. PubMed ID: 18188819
[TBL] [Abstract][Full Text] [Related]
4. Prevention of hepatocellular carcinoma in the Asia-Pacific region: consensus statements.
Asia-Pacific Working Party on Prevention of Hepatocellular Carcinoma
J Gastroenterol Hepatol; 2010 Apr; 25(4):657-63. PubMed ID: 20492323
[TBL] [Abstract][Full Text] [Related]
5. Prevention of hepatocellular carcinoma in patients with chronic hepatitis B virus infection.
Kim BK; Han KH; Ahn SH
Oncology; 2011; 81 Suppl 1():41-9. PubMed ID: 22212935
[TBL] [Abstract][Full Text] [Related]
6. Interferon reduces the risk of hepatocellular carcinoma in hepatitis C virus-related chronic hepatitis/liver cirrhosis.
Masuzaki R; Yoshida H; Omata M
Oncology; 2010 Jul; 78 Suppl 1():17-23. PubMed ID: 20616579
[TBL] [Abstract][Full Text] [Related]
7. Long-term lamivudine therapy reduces the risk of long-term complications of chronic hepatitis B infection even in patients without advanced disease.
Yuen MF; Seto WK; Chow DH; Tsui K; Wong DK; Ngai VW; Wong BC; Fung J; Yuen JC; Lai CL
Antivir Ther; 2007; 12(8):1295-303. PubMed ID: 18240869
[TBL] [Abstract][Full Text] [Related]
8. Prevention of hepatocellular carcinoma complicating chronic hepatitis C.
Ueno Y; Sollano JD; Farrell GC
J Gastroenterol Hepatol; 2009 Apr; 24(4):531-6. PubMed ID: 19368633
[TBL] [Abstract][Full Text] [Related]
9. Prevention and treatment of hepatocellular carcinoma.
Omata M; Yoshida H
Liver Transpl; 2004 Feb; 10(2 Suppl 1):S111-4. PubMed ID: 14762850
[TBL] [Abstract][Full Text] [Related]
10. A sustained virological response to interferon or interferon/ribavirin reduces hepatocellular carcinoma and improves survival in chronic hepatitis C: a nationwide, multicentre study in Taiwan.
Yu ML; Lin SM; Chuang WL; Dai CY; Wang JH; Lu SN; Sheen IS; Chang WY; Lee CM; Liaw YF
Antivir Ther; 2006; 11(8):985-94. PubMed ID: 17302368
[TBL] [Abstract][Full Text] [Related]
11. Prevention and surveillance of hepatitis B virus-related hepatocellular carcinoma.
Liaw YF
Semin Liver Dis; 2005; 25 Suppl 1():40-7. PubMed ID: 16103980
[TBL] [Abstract][Full Text] [Related]
12. [Clinical significance of interferon therapy in treatments for hepatitis C virus-related hepatocellular carcinoma].
Kubo S; Nishiguchi S; Hirohashi K; Tanaka H; Shuto T; Takemura S; Shiomi S; Kinoshita H
Gan To Kagaku Ryoho; 2001 Dec; 28(13):1975-9. PubMed ID: 11791377
[TBL] [Abstract][Full Text] [Related]
13. Interferon therapy in chronic hepatitis B reduces progression to cirrhosis and hepatocellular carcinoma: a meta-analysis.
Yang YF; Zhao W; Zhong YD; Xia HM; Shen L; Zhang N
J Viral Hepat; 2009 Apr; 16(4):265-71. PubMed ID: 19220736
[TBL] [Abstract][Full Text] [Related]
14. Causes of and prevention strategies for hepatocellular carcinoma.
Cabibbo G; Maida M; Genco C; Antonucci M; Cammà C
Semin Oncol; 2012 Aug; 39(4):374-83. PubMed ID: 22846856
[TBL] [Abstract][Full Text] [Related]
15. Changing pattern of hepatocellular carcinoma (HCC) and its risk factors in Egypt: possibilities for prevention.
Anwar WA; Khaled HM; Amra HA; El-Nezami H; Loffredo CA
Mutat Res; 2008; 659(1-2):176-84. PubMed ID: 18346933
[TBL] [Abstract][Full Text] [Related]
16. Molecular therapy and prevention of hepatocellular carcinoma.
Blum HE
Hepatobiliary Pancreat Dis Int; 2003 Feb; 2(1):11-22. PubMed ID: 14599923
[TBL] [Abstract][Full Text] [Related]
17. Hepatocellular carcinoma.
Desjardins LA
Clin J Oncol Nurs; 2002; 6(2):107-8. PubMed ID: 11889672
[TBL] [Abstract][Full Text] [Related]
18. Prevention of hepatocellular carcinoma by universal vaccination against hepatitis B virus: the effect and problems.
Chang MH; Chen TH; Hsu HM; Wu TC; Kong MS; Liang DC; Ni YH; Chen CJ; Chen DS;
Clin Cancer Res; 2005 Nov; 11(21):7953-7. PubMed ID: 16278421
[TBL] [Abstract][Full Text] [Related]
19. The progression of hepatitis B- and C-infections to chronic liver disease and hepatocellular carcinoma: presentation, diagnosis, screening, prevention, and treatment of hepatocellular carcinoma.
Hayashi PH; Di Bisceglie AM
Med Clin North Am; 2005 Mar; 89(2):345-69. PubMed ID: 15656930
[TBL] [Abstract][Full Text] [Related]
20. Development of hepatocellular carcinoma in patients with chronic hepatitis C who had a sustained virological response to interferon therapy: a multicenter, retrospective cohort study of 1124 patients.
Kobayashi S; Takeda T; Enomoto M; Tamori A; Kawada N; Habu D; Sakaguchi H; Kuroda T; Kioka K; Kim SR; Kanno T; Ueda T; Hirano M; Fujimoto S; Jomura H; Nishiguchi S; Seki S
Liver Int; 2007 Mar; 27(2):186-91. PubMed ID: 17311612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
